The orphan receptor GPR55 is a novel cannabinoid receptor

British Journal of Pharmacology

Volumn 152, Issue 7, 2007, Pages 1092-1101

  Ryberg, E ^a   Larsson, N ^a   Sjogren S ^a   Hjorth, S ^a   Hermansson, N O ^a   Leonova, J ^a   Elebring, T ^a   Nilsson, K ^a   Drmota, T ^a   Greasley, P J ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Cannabinoid; G protein coupled receptor; GPR55; Orphan receptor; rhoA

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABIDIOL; CANNABINOID RECEPTOR AGONIST; CANNABINOL; DEXANABINOL; DRONABINOL; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; N OLEOYLETHANOLAMINE; NOLADIN ETHER; O 1602; PALMIDROL; UNCLASSIFIED DRUG; VIRODHAMINE;

ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ARACHIDONIC ACIDS; BINDING SITES; BINDING, COMPETITIVE; CANNABIDIOL; CELL LINE; CLONING, MOLECULAR; CYCLOHEXANOLS; DOWN-REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; POLYUNSATURATED ALKAMIDES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 35649015179     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707460     Document Type: Article

References (47)

1. Anderson-Baker WC, McLaughlin CL, Baile CA (1979). Oral and hypothalamic injections of barbiturates, benzodiazepines and cannabinoids and food intake in rats. Pharmacol Biochem Behav 11: 487-491.
2. Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Ming Mo F et al. (2005). Evidence for novel cannabinoid receptors. Pharmacol Ther 106: 133-145.
3. Berry EM, Mechoulam R (2002). Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95: 185-190.
4. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM et al. (2003). The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. [see comment]. J Biol Chem 278: 11303-11311.
6. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D et al. (2003). The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278: 11312-11319.
7. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC et al. (2000). Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396: 141-149.
8. Cainazzo MM, Ferrazza G, Mioni C, Bazzani C, Bertolini A, Guarini S (2002). Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat. Eur J Pharmacol 441: 91-97.
9. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M et al. (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. [see comment]. J Clin Invest 112: 423-431.
10. Demuth DG, Molleman A (2006). Cannabinoid signalling. Life Sci 78: 549-563.
11. Derocq JM, Jbilo O, Bouaboula M, Segui M, Clere C, Casellas P (2000). Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J Biol Chem 275: 15621-15628.
12. Devane WA, Dysarz III FA, Johnson MR, Melvin LS, Howlett AC (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613.
13. Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM et al. (2000). Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 75: 2434-2444.
14. Franklin A, Parmentier-Batteur S, Walter L, Greenberg DA, Stella N (2003). Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23: 7767-7775.
15. Franklin A, Stella N (2003). Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol- sensitive receptors. Eur J Pharmacol 474: 195-198.
16. Fride E (2002). Endocannabinoids in the central nervous system - an overview. Prostaglandins Leukot Essent Fatty Acids 66: 221-233.
17. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P et al. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232: 54-61.
18. Hajos N, Ledent C, Freund TF (2001). Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106: 1-4.
19. Ho WS, Hiley CR (2003). Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br J Pharmacol 138: 1320-1332.
20. Ho WS, Hiley CR (2004). Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. J Pharm Pharmacol 56: 869-875.
21. Howlett A (2004). Efficacy in CB1 receptor-mediated signal transduction. Br J Pharmacol 142: 1209-1218.
22. Howlett AC (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69: 619-631.
23. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR et al. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96: 14136-14141.
24. Kaplan BL, Rockwell CE, Kaminski NE (2003). Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J Pharmacol Exp Ther 306: 1077-1085.
25. Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ (2002). The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9: 663-674.
26. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A et al. (2005). The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67: 15-19.
27. Maccarrone M, Falciglia K, Di Rienzo M, Finazzi-Agro A (2002). Endocannabinoids, hormone-cytokine networks and human fertility. Prostaglandins Leukot Essent Fatty Acids 66: 309-317.
28. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. [see comment]. Nature 346: 561-564.
29. Mechoulam R (1970a). Marihuana chemistry. Science 168: 1159-1166.
30. Mechoulam R, Shani A, Edery H, Grunfeld Y (1970b). Chemical basis of hashish activity. Science 169: 611-612.
31. Monory K, Tzavara ET, Lexime J, Ledent C, Parmentier M, Borsodi A et al. (2002). Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochem Biophys Res Commun 292: 231-235.
32. Munro S, Thomas KL, Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. [see comment]. Nature 365: 61-65.
33. Noguchi K, Ishii S, Shimizu T (2003). Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278: 25600-25606.
34. Ong WY, Mackie K (1999). A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 92: 1177-1191.
35. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S et al. (2005). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. [see comment]. J Clin Invest 115: 1298-1305.
36. Pacheco MA, Ward SJ, Childers SR (1993). Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. Brain Res 603: 102-110.
37. Parolaro D, Massi P, Rubino T, Monti E (2002). Endocannabinoids in the immune system and cancer. Prostaglandins Leukot Essent Fatty Acids 66: 319-332.
38. Pertwee RG (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180.
39. Pertwee RG (2001). Cannabinoid receptors and pain. Prog Neurobiol 63: 569-611.
40. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH et al. (1999). Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64: 193-198.
41. Sofia RD, Knobloch LC (1976). Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav 4: 591-599.
42. Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG (2007). Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150: 613-623.
43. Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D (2005). Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144: 1032-1036.
44. Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R et al. (1997). Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90: 1448-1457.
45. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K et al. (2005). Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310: 329-332.
46. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G et al. (2003). Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23: 1398-1405.
47. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. [see comment]. Proc Natl Acad Sci USA 96: 5780-5785.